Sean E. Harper

Companies

• AmgenEVP, Research & Development Feb 16, 2012 to Jul 16, 2018¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Recent filings

• May 9, 2023Bought 1,250,000 shares at $18.00 of ACELYRIN, Inc.²
• May 9, 2023Converted 8,540,729 shares of ACELYRIN, Inc.²